Medpace Holdings (MEDP) Cash from Investing Activities (2015 - 2026)
Medpace Holdings (MEDP) posted Cash from Investing Activities of -$6.7 million for Q1 2026, down 50.86% quarter-over-quarter from -$4.5 million in Q4 2025, and up 32.43% year-on-year from -$5.1 million in Q1 2025.
Medpace Holdings (MEDP) Cash from Investing Activities (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Cash from Investing Activities for 12 consecutive years, with -$6.7 million the latest figure, recorded in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$6.7 million, up 32.43% year-over-year; the trailing twelve-month figure through Mar 2026 was -$27.9 million (up 31.66% YoY), and the FY2025 annual result was -$31.1 million, down 10.0% from the prior year.
- Cash from Investing Activities was -$6.7 million for Q1 2026 at Medpace Holdings, down from -$4.5 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $2.5 million in Q1 2024 and troughed at -$12.8 million in Q2 2024.
- Average Cash from Investing Activities over 5 years is -$8.2 million, with a median of -$8.7 million recorded in 2023.
- Year-over-year, Cash from Investing Activities surged 126.62% in 2024 and plunged 494.74% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$9.2 million in 2022, then climbed by 13.26% to -$8.0 million in 2023, then increased by 5.44% to -$7.6 million in 2024, then surged by 40.85% to -$4.5 million in 2025, then sank by 50.86% to -$6.7 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$6.7 million in Q1 2026, -$4.5 million in Q4 2025, and -$10.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -32.14 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -77.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Medpace Holdings | 15.46 Bn | 14.81 Bn | 196.33 Mn | -6.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.75 Mn |
| Mar 31, 2026 | -6.75 Mn |
| Dec 31, 2025 | -4.47 Mn |
| Dec 31, 2025 | -4.47 Mn |
| Sep 30, 2025 | -10.66 Mn |
| Sep 30, 2025 | -10.66 Mn |
| Jun 30, 2025 | -6.02 Mn |
| Jun 30, 2025 | -6.02 Mn |
| Mar 31, 2025 | -9.99 Mn |
| Mar 31, 2025 | -9.99 Mn |
| Dec 31, 2024 | -7.56 Mn |
| Dec 31, 2024 | -7.56 Mn |
| Sep 30, 2024 | -10.49 Mn |
| Sep 30, 2024 | -10.49 Mn |
| Jun 30, 2024 | -12.79 Mn |
| Jun 30, 2024 | -12.79 Mn |
| Mar 31, 2024 | 2.53 Mn |
| Mar 31, 2024 | 2.53 Mn |
| Dec 31, 2023 | -8.00 Mn |
| Dec 31, 2023 | -8.00 Mn |